Fox Chase Cancer Center News

May 15, 2019

Camille Ragin Receives National Cancer Institute R01 Grant to Analyze Role of Genetic Ancestry in Oral Cancer Survival

PHILADELPHIA (May 15, 2019) — Camille Ragin, PhD, has received a grant from the National Cancer Institute for her research on a possible genetic explanation for racial disparities in oral cavity and laryngeal cancer survival rates.

The support of our friends and donors who have made these endowments possible gives us the freedom to pursue yet-uncharted areas.
May 14, 2019

Fox Chase Cancer Center Appoints Five New Endowed Chairs

PHILADELPHIA (May 14, 2019) — Fox Chase Cancer Center has appointed five new endowed chairs.

Private philanthropy is critical to the advancement of cancer research. With sincere gratitude to our donors for their generosity, we at Fox Chase Cancer Center steward our institution’s endowment for the betterment of all who face cancer. It is our pleasure to announce our newly appointed endowed chair holders, to whom we entrust the great responsibility of leading research that will take us further in our understanding of cancer.

Elin R. Sigurdson, MD, PhD, FACS, FRCS (C), director of surgical oncology at Fox Chase, helped initiate the relationship between the two institutions.
May 13, 2019

Fox Chase Cancer Center Launches Clinical Trials Collaboration with China’s Beijing Friendship Hospital

PHILADELPHIA (May 13, 2019) – Fox Chase Cancer Center and Beijing Friendship Hospital in Beijing, China, have initiated a collaborative agreement that will provide both institutions with added capability in cancer clinical trials.

The grant will support Meyer’s effort to accurately identify the genetic profile of the types of tumors arising in younger patients.
May 10, 2019

Joshua Meyer Receives Colorectal Cancer Alliance Grant for Research on Young Onset Colorectal Cancer

PHILADELPHIA (May 10, 2019) — Joshua Meyer, MD, recently received a two-year, $125,000 Chris4Life Grant from the Colorectal Cancer Alliance for a study on genomic alterations central to the development of colorectal cancer in younger adults.

May 9, 2019

Fox Chase Cancer Center Seeks to Educate Individuals on the Signs of Skin Cancer and How to Protect Skin from Sun Damage

PHILADELPHIA (May 9, 2019) – May is Skin Cancer Awareness Month. As you spend more time outdoors this season, it’s important to familiarize yourself with the early signs of skin cancer and learn how you can protect your skin from the sun’s damaging rays.

May 6, 2019

Fox Chase Cancer Center to Offer PAXMAN Scalp Cooling Treatment to Reduce Chemotherapy-Induced Hair Loss

PHILADELPHIA (May 6, 2019) – Fox Chase Cancer Center will be the first cancer center in Philadelphia, along with other top cancer institutions in the US, to offer the PAXMAN Scalp Cooling System, a groundbreaking intervention that reduces hair loss caused by chemotherapy.

May 2, 2019

Fox Chase Cancer Center Earns HAP Achievement Award for Optimal Operations

PHILADELPHIA (May 2, 2019) – Fox Chase Cancer Center has earned a 2019 HAP Achievement Award from The Hospital and Healthsystem Association of Pennsylvania (HAP) for outstanding effort to enhance processes for managing patient discharge planning and care transitions.

Shuanzeng (Sam) Wei, MD, PhD
April 29, 2019

Targeted RNA-Sequencing Detects Fusion Gene Signature in Rare Form of Lung Cancer

PHILADELPHIA (April 29, 2019) — Using next-generation sequencing (NGS) based RNA-sequencing, researchers at Fox Chase Cancer Center found a fusion gene signature in primary tracheobronchial adenoid cystic carcinoma, a rare lung tumor. This study is the first time the MYB/MYBL1 fusion genes have been systemically investigated for this cancer type.


Connect with Fox Chase